Answer
Ravicti (glycerol phenylbutyrate) is indicated as adjunctive therapy for chronic management of urea cycle disorders inadequately controlled by dietary protein restriction and/or amino acid supplementation alone, and must be used with dietary protein restriction and, in some cases, dietary supplements.
Sources for this answer
- RAVICTI 1.1 g/ml oral liquidImmedica · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked